Page 155 - Case Lab Case Analysis

•Raised price of EpiPen more than 400%

•Last six years

•A pack of two EpiPen’s $100 in 2009

•Today: $608
•17 price increases over period

•Mylan’s top-selling product ($1.5bn, 40% of profits)

•Not affordable for families

•No changes or updates to device